AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 3 - (NewsRx.com & NewsRx.net) -- Circulating tumor cells in peripheral blood predict poor survival.
"We investigated the prognostic significance of circulating breast cancer cells in peripheral blood detected by quantitative RT-PCR of marker genes in patients with advanced breast cancer," scientists in Netherlands report.
"Blood samples from 94 breast cancer patients with metastatic disease (MI) were examined for circulating tumor cells by studying the mRNA expression of CK 19, pIB, PS2 and EGP2 by real-time PCR," wrote B. Weigelt and colleagues, Netherlands Cancer Institute, Department of Pathology.
"Using a score function developed for predicting circulating tumor cells by quadratic discriminant analysis (QDA), the four expression levels were combined into a single discriminant value. Tumor cells were present in 24 out of 94 (31%) of the patients," the researchers wrote.
"In 77% (72 out of 94) of the patients distant metastatic disease was localized in the bone. In 36% (26 out of 72) of the patients with bone metastases at the time of blood sampling, a positive QDA for the four genes was found, in contrast to only 14% (three out of 22) without bone involvement," the researchers stated.
"Overall survival rates by Kaplan-Meier revealed no ...
Source: HighBeam Research, Circulating tumor cells in peripheral blood predict poor survival.